Myocardial SPECT perfusion defect size compared to infarct size by delayed gadolinium-enhanced magnetic resonance imaging in patients with acute or chronic infarction

Clinical Physiology and Functional Imaging

Volumn 24, Issue 6, 2004, Pages 380-386

  Hedström, Erik ^a   Palmer, John ^a   Ugander, Martin ^a   Arheden, Håkan ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Magnetic resonance imaging; Myocardial infarction; Myocardial ischaemia; Perfusion; Scintigraphy; Single photon emission computed tomography

Indexed keywords

GADOLINIUM; GADOLINIUM PENTETATE MEGLUMINE; GADOTERIC ACID; TETROFOSMIN TC 99M;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; FEMALE; HEART INFARCTION SIZE; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE REVASCULARIZATION; HUMAN; INTERMETHOD COMPARISON; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 8844254720     PISSN: 14750961     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1475-097X.2004.00579.x     Document Type: Article

References (39)

1. Arheden H, Saeed M, Higgins CB, Gao DW, Bremerich J, Wyttenbach R, Dae MW, Wendland MF. Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction: comparison with 99mTc-DTPA autoradiography in rats. Radiology (1999); 211: 698-708.
2. Arrighi JA, Ng CK, Dey HM, Wackers FJ, Soufer R. Effect of left ventricular function on the assessment of myocardial viability by technectium-99m sestamibi and correlation with positron emission tomography in patients with healed myocardial infarcts or stable angina pectoris, or both. Am J Cardiol (1997); 80: 1007-1013.
3. Behrenbeck T, Pellikka PA, Huber KC, Bresnahan JF, Gersh BJ, Gibbons RJ. Primary angioplasty in myocardial infarction: assessment of improved myocardial perfusion with technetium-99m isonitrile. J Am Coll Cardiol (1991); 17: 365-372.
4. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet (1986); 1: 307-310.
5. Braunwald E. The path to myocardial salvage by thrombolytic therapy. Circulation (1987); 76: II2-II7.
6. Braunwald F. Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival. Should the paradigm be expanded? Circulation (1989); 79: 441-444.
7. Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation (1982); 66: 1146-1149.
8. Braunwald E, Rutherford JD. Reversible ischemic left ventricular dysfunction: evidence for the "hibernating myocardium". J Am Coll Cardiol (1986); 8: 1467-1470.
9. Caputo GR, Tscholakoff D, Sechtem U, Higgins CB. Measurement of canine left ventricular mass by using MR imaging. AJR Am J Roentgenol (1987); 148: 33-38.
10. Certain L, Verna E, Giovanella L, Bianchi L, Roncari G, Tarolo GL. Assessment of myocardial area at risk by technetium-99m sestamibi during coronary artery occlusion: comparison between three tomographic methods of quantification. Eur J Nucl Med (1996); 23 31-39.
11. Chareonthaitawee P, Schaefers K, Baker CS, Turkheimer F, Stegger L, Banner NR, Yacoub M, Bonser RS, Iozzo P, Camici PG, Rimoldi O. Assessment of infarct size by positron emission tomography and [18F]2-fluoro-2-deoxy-D-glucose: a new absolute threshold technique. Eur J Nucl Med Mol Imaging (2002); 29: 203-215.
12. Eisner RL, Patterson RE. The challenge of quantifying defect size and severity: reality versus algorithm. J Nucl Cardiol (1999 ; 6: 362-371.
13. Elkamhawy AA, Chandna H. Minimum detectable defect thickness in SPECT myocardial perfusion test: phantom study with (99m)Tc and (201)Tl. J Nucl Med Technol (2001); 29: 183-188.
14. Feild BJ, Russell RO, Jr, Dowling JT, Rackley CE. Regional left ventricular performance in the year following myocardial infarction. Circulation (1972); 46: 679-689.
15. Fieno DS, Kim RJ, Chen EL, Lomasney JW, Klocke FJ, Judd RM. Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing. J Am Coll Cardiol (2000); 36: 1985-1991.
16. Flacke SJ, Fischer SE, Lorenz CH. Measurement of the gadopentetate dimeglumine partition coefficient in human myocardium. in vivo: normal distribution and elevation in acute and chronic infarction. Radiology (2001); 218: 703-710.
17. Germano G, Kavanagh PB, Waechter P, Areeda J, Van Krickinge S, Sharir T, Lewin HC, Berman DS. A new algorithm for the quantitation of myocardial perfusion SPECT. I: technical principles and reproducibility. J Nucl Med (2000); 41: 712-719.
18. Gibbons RJ, Christian TF, Hoplenspirger M, Hodge DO, Bailey KR. Myocardium at risk and infarct size after thrombolytic therapy for acute myocardial infarction: implications for the design of randomized trials of acute intervention. J Am Coll Cardiol (1994); 24: 616-623.
19. Gibbons RJ, Miller TD, Christian TF. Tnfarct size measured by single photon emission computed tomographic imaging with (99m)Tc-sestamibi: a measure of the efficacy of therapy in acute myocardial infarction. Circulation (2000); 101: 101-108.
20. Hinohora T, Wagner NB, Cobb FR, Coleman RE, Pope JE, Haisty WK, Wagner GS. An ischemic index from the electrocardiogram to select patients with low left ventricular ejection fraction for coronary artery bypass grafting. Am J Cardiol (1988); 61: 288-291.
21. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd RM. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation (1999); 100: 1992-2002.
22. King MA, Long DT, Brill AB. SPECT volume quantitation: influence of spatial resolution, source size and shape, and voxel size. Med Phys (1991); 18: 1016-1024.
23. Kloner RA, Arimie RB, Kay GL, Cannom D, Matthews R, Bhandari A, Shook T, Pollick C, Burstein S. Evidence for stunned myocardium in humans: a 2001 update. Coron Artery Dis (2001); 12: 349-356.
24. Kojima A, Matsumoto M, Takahashi M, Hirota Y, Yoshida H. Effect of spatial resolution on SPECT quantification values. J Nucl Med (1989); 30: 508-514.
25. Licka M, Zimmermann R, Zehelein J, Dengler TJ, Katus HA, Kubler W. Troponin T concentrations 72 hours after myocardial infarction as a serological estimate of infarct size. Heart (2002); 87: 520-524.
26. Lund GK, Wendland MF, Shimakawa A, Arheden H, Stahlberg F, Higgins CB, Saeed M. Coronary sinus flow measurement by means of velocity-encoded cine MR imaging: validation by using flow probes in dogs. Radiology (2000); 217: 487-493.
27. Lund GK, Higgins CB, Wendland MF, Watzinger N, Weinmann HJ, Saeed M. Assessment of nicorandil therapy in ischemic myocardial injury by using contrast-enhanced and functional MR imaging. Radiology (2001); 221: 676-682.
28. Medrano R, Lowry RW, Young JB, Weilbaecher DG, Michael LH, Afridi I, He ZX, Mahmarian JJ, Verani MS. Assessment of myocardial viability with 99mTc sestamibi in patients undergoing cardiac transplantation. A scintigraphic/pathological study. Circulation (1996); 94: 1010-1017.
29. Miller TD, Christian TF, Hopfenspirger MR, Hodge DO, Gersh BJ, Gibbons RJ. Infarct size after acute myocardial infarction measured by quantitative tomographic 99mTc sestamibi imaging predicts subsequent mortality. Circulation (1995); 92: 334-341.
30. Reimer KA, Lowe JE, Rasmussen MM, Jennings RB. The wavefront phenomenon of ischemic cell death. 1. Myocardial infaret size vs duration of coronary occlusion in dogs. Circulation (1977); 56: 786-794.
31. Saeed M, Wendland MF, Masui T, Higgins CB. Reperfused myocardial infarctions on Tl - and susceptibility-enhanced MRI: evidence for loss of compartmentalization of contrast media. Magn Reson Med (1994); 31: 31-39.
32. Sharir T, Germano G, Waechter PB, Kavanagh PB, Areeda JS, Gerlach J, Kang X, Lewin HC, Berman DS. A new algorithm for the quantitation of myocardial perfusion SPECT. II: validation and diagnostic yield. J Nucl Med (2000); 41: 720-727.
33. Shen WK, Khandheria BK, Edwards WD, Oh JK, Miller FA Jr, Naessens JM, Tajik AJ. Value and limitations of two-dimensional echocardiography in predicting myocardial infarct size. Am J Cardiol (1991); 68: 1143-1149.
34. Simonetti OP, Kim RJ, Fieno DS, Hillenbrand HB, Wu E, Bundy JM, Finn JP, Judd RM. An improved MR imaging technique for the visualization of myocardial infarction. Radiology (2001); 218 215-223.
35. Smith WH, Kastner RJ, Calnon DA, Segalla D, Beller GA, Watson DD. Quantitative gated single photon emission computed tomography imaging: a counts-based method for display and measurement of regional and global ventricular systolic function. J Nucl Cardiol (1997); 4: 451-463.
36. Tong CY, Prato FS, Wisenberg G, Lee TY, Carroll E, Sandler D, Wills J, Drost D. Measurement of the extraction efficiency and distribution volume for Gd-DTPA in normal and diseased canine myocardium. Magn Reson Med (1993); 30: 337-346.
37. Wagner A, Mahrholdt H, Holly TA, Elliott MD, Regenfus M, Parker M, Klocke FJ, Bonow RO, Kim RJ, Judd RM. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet (2003); 361: 374-379.
38. van der Wall EE, Niemeyer MG, de Roos A, Bruschke AV, Pauwels EK. Infarct sizing by scintigraphic techniques and nuclear magnetic resonance imaging. Eur J Nucl Med (1990); 17: 83-90.
39. Warren SE, Royal HD, Markis JE, Grossman W, McKay RG. Time course of left ventricular dilation after myocardial infarction: influence of infarct-related artery and success of coronary thrombolysis. J Am Coll Cardiol (1988); 11: 12-19.